NGS and phenotypic ontology-based approaches increase the diagnostic yield in syndromic retinal diseases.
NGS and phenotypic ontology-based approaches increase the diagnostic yield in syndromic retinal diseases.
复制标题
DOI:
10.1007/s00439-021-02343-7
复制
发表时间:
2021-12
期刊:
影响因子:
5.3
通讯作者:
Ayuso C
中科院分区:
文献类型:
--
作者:
Perea-Romero I;Blanco-Kelly F;Sanchez-Navarro I;Lorda-Sanchez I;Tahsin-Swafiri S;Avila-Fernandez A;Martin-Merida I;Trujillo-Tiebas MJ;Lopez-Rodriguez R;Rodriguez de Alba M;Iancu IF;Romero R;Quinodoz M;Hakonarson H;Garcia-Sandova B;Minguez P;Corton M;Rivolta C;Ayuso C
Syndromic retinal diseases (SRDs) are a group of complex inherited systemic disorders, with challenging molecular underpinnings and clinical management. Our main goal is to improve clinical and molecular SRDs diagnosis, by applying a structured phenotypic ontology and next-generation sequencing (NGS)-based pipelines. A prospective and retrospective cohort study was performed on 100 probands with an a priori diagnosis of non-Usher SRDs, using available clinical data, including Human Phenotype Ontology annotation, and further classification into seven clinical categories (ciliopathies, specific syndromes and five others). Retrospective molecular diagnosis was assessed using different molecular and bioinformatic methods depending on availability. Subsequently, uncharacterized probands were prospectively screened using other NGS approaches to extend the number of analyzed genes. After phenotypic classification, ciliopathies were the most common SRD (35%). A global characterization rate of 52% was obtained, with six cases incompletely characterized for a gene that partially explained the phenotype. An improved characterization rate was achieved addressing prospective cases (83%) and well-recognizable syndrome (62%) subgroups. The 27% of the fully characterized cases were reclassified into a different clinical category after identification of the disease-causing gene. Clinical-exome sequencing is the most appropriate first-tier approach for prospective cases, whereas whole-exome sequencing and bioinformatic reanalysis increases the diagnosis of uncharacterized retrospective cases to 45%, mostly those with unspecific symptoms. Our study describes a comprehensive approach to SRDs in daily clinical practice and the importance of thorough clinical assessment and selection of the most appropriate molecular test to be used to solve these complex cases and elucidate novel associations. The online version contains supplementary material available at 10.1007/s00439-021-02343-7.
登录
查看更多内容
影响因子:
11.8
作者:
Guo J;Otis JM;Higginbotham H;Monckton C;Cheng J;Asokan A;Mykytyn K;Caspary T;Stuber GD;Anton ES
通讯作者:
Anton ES
影响因子:
12.3
作者:
Ayuso C;Millan JM
通讯作者:
Millan JM
影响因子:
3.5
作者:
Li, Jinliang;Gao, Kai;Jiang, Yuwu
通讯作者:
Jiang, Yuwu
影响因子:
5.2
作者:
Forsythe, Elizabeth;Beales, Philip L.
通讯作者:
Beales, Philip L.
DOI:
10.1073/pnas.1913179117
发表时间:
2020-02-04
影响因子:
11.1
作者:
Hanany, Mor;Rivolta, Carlo;Sharon, Dror
通讯作者:
Sharon, Dror